Plan B Comment Review Concerns Prompt Request For Second GAO Report
This article was originally published in The Tan Sheet
A request by Democratic Sens. Hillary Clinton (N.Y.) and Patty Murray (Wash.) for a GAO investigation into FDA's outsourcing of public comment review for Plan B is the latest effort by the lawmakers to encourage a decision on the Rx-to-OTC switch application
You may also be interested in...
Plan B comment analysis is being handled by an outside contractor with oversight by FDA's Office of Policy, according to Acting Commissioner Andrew von Eschenbach, MD
The Government Accountability Office's investigation into FDA's initial denial of Plan B discovered that the agency's decision to issue a "not approvable" letter did not reflect the opinions of scientific review staff.
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation